Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2a Study Evaluating the Arsenic Trioxide (ATO) in Systemic Lupus (SLE)

NCT01738360 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT01738360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01738360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2a Study Evaluating the Arsenic Trioxide (ATO) in Systemic Lupus (SLE)
Lead sponsor
Nantes University Hospital
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2013
Completion date
October 31, 2015
Enrollment
11 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus